tirzepatide alternatives 2025 Important update: Tirzepatide will soon be discontinued, but don't worry! We've got you covered with our new offering Tirzepatide Leads Pharma Growth in

They can also potentially trigger or worsen common GLP-1 side effects like nausea and bloating

Rothhammer V, Mascanfroni ID, Bunse L, et al

Whilst the FDA approved the use of oral semaglutide for the treatment of people with T2D in September 2019 [37], the EMA have not approved its use in T2D at the time of writing

Compounded peptides from licensed compounding pharmacies operating under physician prescription are subject to more oversight than online vendors, but the FDA placed restrictions on compounded peptides in 2023 due to safety and quality concerns

Children, unless under professional guidance

Verdict at a Glance Semaglutide is the established gold standard with FDA approval, proven cardiovascular benefit, extensive clinical data, and multiple formulation options